Thyrocare Technologies Limited –Share lists at 49%premium, closes at 38%

Thyrocare Technologies Limited which had offered 1.07 cr shares in a secondary offering at a price band of Rs 420-446 and allotted at Rs 446 listed yesterday. The company had allotted 32.23 lac shares to 15 anchor investors comprising of 29 entities. The public issue was very well received and was oversubscribed a massive 73.55 times with QIB portion 73 times, HNI portion 225 times and retail portion 8.72 times.

The cost of funding was between Rs 180-190 per share depending upon the rate of interest. HNI Investors were sitting pretty till the date of listing as the premium in the grey market was about Rs 240-250. The share made its debut on Monday and the discovered price on the NSE was Rs 665 while it was lower at Rs 662 on the BSE. The share made its high almost immediately and then drifted down before closing at Rs 618.10 on the BSE and Rs 616.50 on the NSE. Investors made money but only those who applied with their own money. Those leveraged investors who thought making money was so easy and just borrowed and applied actually lost money. The weighted average of the day’s trade was Rs 623.99 on the BSE and Rs 625.02 on the NSE, implying a spread of under Rs 180 on either exchange. Add transaction costs and almost all leveraged investors would have lost money. However the financers of these transactions would be laughing their way and counting their profits as they have made a bomb. The total demand in the issue was a whopping Rs 16,000 crs plus from HNI’s and virtually risk free as even assuming a margin of 2%, the allotment was just around half a percent.

Exchange Open High Low Close Net Change % Gain/loss Wt. Avg Volume Delivery Del %age
BSE 662.00 665.40 606.00 618.10 172.10 38.59 623.99 2678027 597986 22.33
NSE 665.00 665.00 605.80 616.50 170.50 38.23 625.02 12860078 3606791 28.05
Total               15538105 4204777 27.06

From the table above one can see that the total volume on the two exchanges was 155.38 lac shares which was 1.45 times the IPO size. Delivery volume was 42.07 lakh shares which was 27.06% of the traded volume and 39.13% of the IPO size. If one considers the fact that the anchor portion comes with a lock-in, the delivery percentage of non-anchor was a massive 55.90%. Assuming retail and HNI’s have cashed out in profit or loss it means that 25% of the book has delivered but the remaining shares can only come from QIB’s. It means making 40% return in about ten days would be tempting for anyone.

This brings me back to my favourite them of allowing HNI’s to apply for one time the whole book even though there allocation is either 10% or 15%. They do two three things which should rattle the regulator. Firstly they distort demand and give a skewed picture. Second they are the group of people who have a direct interest in their being a grey market which is illegal and any regulator should be unhappy about. Thirdly they have to sell on listing day irrespective of profit or loss and they therefore bring undue pressure on the share. They also make a good issue mediocre as has happened in the case of Thyrocare where a price discovery of Rs 665 against an issue price of Rs 446 was just not enough and the share fell.
One hopes that the regulator will someday realise what distortion one simple rule of SEBI is doing.

Thyrocare Technologies Limited – Subscribed 73 times

The secondary offering from Thyrocare Technologies which opened for subscription on Wednesday the 27th of April and closed on Friday the 29th of April received excellent support and was oversubscribed 73 times. The leveraged HNI subscribed his bucket size 225 times. And would still make money considering that the grey market premium is in the region of Rs 250. One wonders whether the present primary market is a nexus between the financers which are directly or indirectly an arm of merchant bankers and these leveraged investors who distort the demand and create such high subscription. One wonders whether SEBI has ever looked into this issue where a single individual from the HNI category where the bucket size is either 10% or 15% of the whole issue is permitted to subscribe to the whole issue. Secondly till today there hardly seems an instance where the spill over has happened from retail to HNI or QIB to HNI to warrant such subscription.

Thyrocare Technologies revised price band was Rs 420-446 and the issue was to raise Rs 479 crs at the top end of the band through a secondary offering. The detailed subscription in various categories is given below: –

Bucket Size Shares Applied for Times oversubscribed
QIB 2148942 157252095 73.1765
HNI 1611707 363122892 225.3033
Retail 3760648 32822724 8.7279
Total 7521297 553197711 73.5508

Choppy markets but active primary market

Markets seem to be going nowhere and lost ground for the second consecutive week. The BSESENSEX and NIFTY were down an identical 1.48%. The broader markets lost a little less and almost all sectoral indices were in the negative. The markets are in a volatile mode and seem to be alternating between gains and losses on a daily basis.

The action seems to be in the primary market where one IPO completed its subscription and another extended the issue on not being subscribed. In the current week we would see two listings on Monday and Tuesday and both these issues would generate handsome returns for lucky investors. There are likely to be some more issues opening towards the end of the month.

The failure of Parag to get subscribed after raising Rs 343 crs would raise many eyebrows. The company needed a further Rs 240 crs from QIB’s and managed a mere Rs 120 crs. The issue has been extended and would now close on Wednesday the 11th of May. The price band too has been revised from Rs 220-227 to Rs 215-227. To know more read the article on Parag on the website.

ICICI had made huge provisions for potential losses from deteriorating asset quality and it would be interesting to see what PSU bands do this week when they would have to declare results. If the AQR (asset quality review) is anything to go by, the worst is more or less behind us and things should improve going forward in a quarter or thereabout.

A lot seems to be happening in parliament and the tension is clear. The good thing is that there is some work happening. Further clarity will emerge once the floor test in Uttrakhand is over. The last round of voting would be over by the end of the week and on 19th May the results for the five states would be declared. Statistically speaking the ruling party has virtually no seats in the states going to polls but they have a lot at stake particularly in Assam. The outcome of elections may act as a trigger to the market. The most awaited event however continues to be the onset of monsoon over Kerala. The beginning of the rain in Kerala would bring cheer to people all around particularly the markets where a lot hinges on this monsoon.

Markets would continue to be choppy and see two sided movements. If you have the conviction go long and hold on with adequate stop losses.

 

Subscribe to RSS Feed Follow me on Twitter!